Drugs / IG-RD-001
IG-RD-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00862225 | Jan → Apr 2008 | seasonal allergic rhinitis | Max Zeller Soehne AG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IG-RD-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00862225 ↗ |
| Known as | petasol butenoate complex | “Petasites hybridus leaf extract IG-RD-001 (Ze-339, petasol butenoate complex)” NCT00862225 ↗ |
| Known as | Ze 339 | “Petasites hybridus leaf extract IG-RD-001 (Ze-339, petasol butenoate complex)” NCT00862225 ↗ |